Top Stocks, ETFs & Cryptocurrencies

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

Uxin Ltd is an investment holding company. Along with its subsidiaries the firm operates used car e-commerce platforms through its mobile applications and websites.

Himax Technologies Inc is a fabless semiconductor solution provider dedicated to display imaging processing technologies. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, and digital cameras.

New Age Beverages Corp is engaged in positioning itself as a healthy beverage company integrating its búcha Live Kombucha business, strengthening the businesses foundation and processes.

Progenics Pharmaceuticals Inc is a biopharmaceutical company that develops innovative medicines and other technologies to identify, target and treat cancer. Its pipeline drugs include AZEDRA and 1095; 1404 and PyL; and imaging analysis tools.

Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease.

Gogo Inc is a US-based in-flight connectivity systems and service provider. The company through aero communications, in-flight broadband, and wireless in-cabin digital entertainment solutions for the aviation industry across the world.

Gol Intelligent Airlines Inc is a low-cost carrier that provides regular and non-regular air transportation services of passengers, cargo and mailbags, domestically or internationally.

DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

Keane Group Inc is a provider of integrated well completion services in the U.S. Its services include hydraulic fracturing, engineered solutions, wireline technologies and coiled tubing. It also provides drilling & well construction services.

Lannett Co Inc develops, manufactures, packages, markets and distributes generic versions of branded pharmaceutical products. Its products include solid oral dosage forms, including oral solutions, nasal, topicals or parentarels.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

The investment seeks to replicates, net of expenses, the S&P GSCI Enhanced Commodity Total Return Strategy Index. The index reflects the total returns that are potentially available through an unleveraged investment in the same futures contracts as are included in the S&P GSCI.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the MSCI India Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the large- and mid-capitalization segments of the Indian equity market, covering approximately 85% of the Indian equity universe. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the MSCI Mexico IMI 25/50 Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the large-, mid- and small-capitalization segments of the Mexican equity market, covering approximately 99% of the free float-adjusted market capitalization in Mexico. The fund is non-diversified.

The investment seeks to replicate, net of expenses, three times the opposite (inverse) of this GSCI Natural Gas Index ER. The index comprises futures contracts on a single commodity and is calculated according to the methodology of the S&P GSCI Index.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the MSCI Brazil 25/50 Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the large- and mid-capitalization segments of the Brazilian equity market, covering approximately 85% of the free float-adjusted market capitalization of Brazilian issuers. It is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Latin America 40 Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is a float-adjusted market capitalization weighted equity index of issuers drawn from five major Latin American markets: Brazil, Chile, Columbia, Mexico, and Perú. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the FTSE China 50 Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index consists of the 50 largest and most liquid public Chinese companies currently trading on the Hong Kong Stock Exchange ("SEHK"). The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the MSCI Korea 25/50 Index. The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the large- and mid-cap segments of the South Korean equity market, covering approximately 85% of the free float-adjusted market capitalization of South Korean issuers. It is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Dynamic Pharmaceutical Intellidex Index (the "index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index consists of common shares of companies that are principally engaged in research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

A description is not currently available for this symbol.

The investment seeks to replicate, net of expenses, three times the performance of the S&P GSCI Natural Gas Index ER. The index comprises futures contracts on a single commodity and is calculated according to the methodology of the S&P GSCI Index.

A description is not currently available for this symbol.

The investment seeks daily investment results, of 300% of the inverse (or opposite) of the daily performance of the S&P Oil & Gas Exploration & Production Select Industry Index. The fund invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

The investment seeks results for a single day that match (before fees and expenses) two times the daily performance of the Bloomberg Natural Gas SubindexSM. The fund seeks to meet their investment objectives by investing under normal market conditions in Natural Gas futures contracts. It may also invest in swaps if the market for a specific futures contract experiences emergencies (e.g., natural disaster, terrorist attack, or an act of God) or disruptions (e.g., a trading halt or a flash crash) that would prevent or make it impractical for such fund to obtain the appropriate amount of investment exposure to the affected Natural Gas futures contracts directly.

The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index®. The fund invests in derivatives that the advisor believes, should have similar daily return characteristics as three times the inverse of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the MSCI EAFE® Index. The fund invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is a free float-adjusted market capitalization index that is designed to measure the performance of large- and mid-capitalization companies from the 21 developed market countries. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the FTSE China 50 Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index consists of the 50 largest and most liquid public Chinese companies currently trading on the Hong Kong Stock Exchange ("SEHK"). The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the MSCI Emerging Markets IndexSM. The fund invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is a free float-adjusted market capitalization weighted index that is designed to represent the performance of large- and mid-capitalizations securities across the 24 emerging market countries. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the MSCI Brazil 25/50 Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a free-float-adjusted, market capitalization-weighted index that is designed to measure the equity market performance of the Brazilian market. The fund is non-diversified.

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the PHLX Semiconductor Sector Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index measures the performance of domestic companies engaged in the design, distribution, manufacture and sale of semiconductors. The fund is non-diversified.

Waves NG is making the platform easier and faster. It allows us to handle hundreds of transactions per second and means we are the fastest blockchain in the world.

Waves NG is making the platform easier and faster. It allows us to handle hundreds of transactions per second and means we are the fastest blockchain in the world.

Augur is built from the ground up to be owned and operated by the people that use it. This is a technical reality enabled by the Ethereum blockchain and open source software.

Augur is built from the ground up to be owned and operated by the people that use it. This is a technical reality enabled by the Ethereum blockchain and open source software.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

Waves NG is making the platform easier and faster. It allows us to handle hundreds of transactions per second and means we are the fastest blockchain in the world.

A description is not currently available for this symbol.

https://www.binance.com/aboutUs.html

https://www.binance.com/aboutUs.html

Bytecoin is an open-sourced decentralized cryptocurrency with untraceable payments that was started in 2012.

Bytecoin is an open-sourced decentralized cryptocurrency with untraceable payments that was started in 2012.

A description is not currently available for this symbol.

The Hcash platform is designed to be a side chain for both block-based and blockless-based blockchains.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

A description is not currently available for this symbol.

VeChain aims to connect blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model as well as advanced IoT integration, and pioneers in real world applications.

VeChain aims to connect blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model as well as advanced IoT integration, and pioneers in real world applications.